M&A news

Revvity Acquires Tecan to Enhance Healthcare Innovation and Global Reach

Tecan acquired by Revvity

AcquisitionHealthcare

Get the full Tecan company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Tecan logo
Acquired

Tecan

Biotechnology Research

Undisclosed amount

April 23, 2025

Revvity logo
Acquirer

Revvity

Biotechnology Research

### Revvity Acquires Tecan: A Strategic Move to Enhance Healthcare Innovation

In a decisive step towards scaling healthcare innovation, Revvity has announced its acquisition of Tecan, a prominent player in life sciences and diagnostics, for an undisclosed amount. This acquisition marks a significant shift in the landscape of healthcare technology, aiming to integrate cutting-edge automation and life science solutions into clinical practices worldwide.

Founded in Switzerland, Tecan has established itself as a leader in lab automation and liquid handling solutions, dedicated to improving health outcomes through precise, reproducible lab processes. The company collaborates with healthcare professionals and researchers globally, ensuring the seamless implementation of innovative solutions from the lab to the clinic. Revvity, on the other hand, is renowned for its commitment to accelerating innovation in life sciences through advanced imaging and data analytics technologies.

The strategic rationale behind this acquisition lies in the complementary strengths of both companies. By integrating Tecan's robust automation capabilities with Revvity's expertise in data analytics and imaging, the combined entity is poised to offer comprehensive solutions that enhance precision in diagnostics and streamline workflows. “This acquisition allows us to leverage Tecan’s established market presence and advanced technology to deliver greater value to our customers and ultimately improve patient outcomes,” said a hypothetical executive from Revvity.

The acquisition could potentially reshape industry dynamics by creating a more integrated ecosystem of healthcare technology. As healthcare shifts towards personalized medicine, the demand for innovative solutions that can provide rapid diagnostics and treatment options will grow. The combined capabilities of Revvity and Tecan position them to capitalize on this trend, potentially leading to increased market share and influence in the healthcare sector.

Looking ahead, this acquisition signifies a commitment to advancing healthcare innovation. As Revvity and Tecan work together, they are likely to set new standards in lab automation and diagnostics, paving the way for improved patient care and enhanced operational efficiency in clinical settings. The healthcare landscape may very well be entering a new era of innovation, driven by this strategic partnership.

Buying signals & intent

Our AI suggests Tecan may be interested in:

Research and Development
Biotechnology
Pharmaceuticals
Medical Devices
Automation Solutions

Unlock GTM signals

Discover Tecan's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Tecan.

Unlock decision-makers